The new device can continuously sense levels of virtually any protein or molecule in the blood. The researchers say it could be transformative for disease detection, patient monitoring and biomedical research.
Artificial neural networks open up new possibilities in interpreting the time-consuming imaging ´data.
By analyzing Fitbit data and self-reported symptoms, researchers analyzed trends in heart rate, step count, and symptom duration between patients with flu and those with COVID-19.
A new eye test may predict wet age-related macular degeneration, a leading cause of severe sight loss, three years before symptoms develop.
Scientists developed the world’s first mobile genome sequence analyzer, a new iPhone app called iGenomics.
A stretchable system that can harvest energy from human breathing and motion for use in wearable health-monitoring devices may be possible.
Researchers have developed a smartwatch app designed to alert users when their bodies show signs of fighting an infection, such as elevated heart rate.
A smart ring that generates continuous temperature data may foreshadow COVID-19, even in cases when infection is not suspected.
If Alzheimer's dementia is identified early, the decline in neural functioning can be stabilized or even curtailed in some cases.
Researchers have developed a rapid, ultrasensitive test using a paper-based electrochemical sensor that can detect the presence of the virus in less than five minutes.
AI is growing ever more powerful and entering people’s daily lives, yet often we don’t know what goes on inside these systems.
Engineers have developed a diagnostic tool, based on nuclear magnetic resonance, that could be used to detect fatty liver disease and liver fibrosis.
Two deep learning algorithms that identify patterns of COVID-19 in lung images and breath sounds, may help in the fight against other respiratory diseases and the growing challenge of antibiotic resistance.
Researchers have invented a high-throughput cell separation method that can be used in conjunction with droplet microfluidics.
A tiny new silicon-based lab-on-chip test could pave the way for cheap handheld infectious disease testing.
Researchers are developing solutions designed to enable the analysis of breath gas to assist with the diagnosis of disease.
Researchers have developed an AI tool that can measure the volume of cerebral ventricles on MRIs in children within about 25 minutes.
Researchers have shown that graphene quantum dots – a form of graphene with applications in both diagnostics and therapy – are biodegradable by two enzymes found in the human body.
Microneedle patches could provide a means for extracting interstitial fluid to study possible new biomarkers.
The quantum sensing abilities of nanodiamonds can be used to improve the sensitivity of paper-based diagnostic tests, potentially allowing for earlier detection of diseases such as HIV.
Researchers have developed a new AI platform that detects COVID-19 by analyzing X-ray images of the lungs.
AI offers not only the possibility of better detection of a tumor, a skin lesion or some other indication but also can improve accuracy and efficiency for radiologists.
Researchers at the Terasaki Institute have developed prototypes of contact lenses that can assist with tear sampling for diagnostic purposes.
Results of the first clinical trial of 3D printed NP swabs for COVID-19 testing are being presented at the annual meeting RSNA.
A new approach uses a nanosensor to speed up detection of trace amounts of biomarkers for early-disease diagnosis, while retaining high levels of sensitivity.
Point-of-care electrochemical sensors using revolutionary nanocarbon technology can rapidly test for opioid concentrations in the bloodstream.
COMPAMED 2020 took place entirely online due to the pandemic - but still won over their audiences due to their high degree of international resonance in this format too.
Researchers created a novel deep learning method that makes automated screenings for eye diseases such as diabetic retinopathy more efficient.
With soaring demand for point-of-care testing (POCT), microfluidics has been a pivotal resource as COVID-19 swept across the world.
